25 XP   0   0   10

Guangxi Liuzhou Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Guangxi Liuzhou Pharm Co Ltd together

PenkeI guess you are interested in Guangxi Liuzhou Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangxi Liuzhou Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangxi Liuzhou Pharm Co Ltd

I send you an email if I find something interesting about Guangxi Liuzhou Pharm Co Ltd.

Quick analysis of Guangxi Liuzhou Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Guangxi Liuzhou Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥18.99
Expected worth in 1 year
¥20.76
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.98
Return On Investment
14.2%

For what price can you sell your share?

Current Price per Share
¥21.09
Expected price per share
¥15.12 - ¥23.64
How sure are you?
50%

1. Valuation of Guangxi Liuzhou Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥21.09

Intrinsic Value Per Share

¥40.94 - ¥48.76

Total Value Per Share

¥59.93 - ¥67.75

2. Growth of Guangxi Liuzhou Pharm Co Ltd (5 min.)




Is Guangxi Liuzhou Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$952.1m$833.8m$83m9.1%

How much money is Guangxi Liuzhou Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$27.7m$22.1m$5.5m20.0%
Net Profit Margin3.9%3.4%--

How much money comes from the company's main activities?

3. Financial Health of Guangxi Liuzhou Pharm Co Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#11 / 42

Most Revenue
#16 / 42

Most Profit
#12 / 42

What can you expect buying and holding a share of Guangxi Liuzhou Pharm Co Ltd? (5 min.)

Welcome investor! Guangxi Liuzhou Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Guangxi Liuzhou Pharm Co Ltd.

What can you expect buying and holding a share of Guangxi Liuzhou Pharm Co Ltd?

First you should know what it really means to hold a share of Guangxi Liuzhou Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangxi Liuzhou Pharm Co Ltd is ¥21.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangxi Liuzhou Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangxi Liuzhou Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥18.99. Based on the TTM, the Book Value Change Per Share is ¥0.44 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.30 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangxi Liuzhou Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.090.4%0.080.4%0.060.3%0.070.3%0.050.2%
Usd Book Value Change Per Share0.090.4%0.060.3%0.050.2%0.060.3%0.070.3%
Usd Dividend Per Share0.010.0%0.040.2%0.040.2%0.030.2%0.030.1%
Usd Total Gains Per Share0.100.5%0.100.5%0.080.4%0.090.4%0.100.5%
Usd Price Per Share2.99-3.10-2.41-3.29-5.27-
Price to Earnings Ratio8.44-10.67-12.75-13.50-39.86-
Price-to-Total Gains Ratio29.09-38.83-39.80-40.25-103.26-
Price to Book Ratio1.14-1.22-1.05-1.66-5.27-
Price-to-Total Gains Ratio29.09-38.83-39.80-40.25-103.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.918856
Number of shares342
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.060.06
Usd Total Gains Per Share0.100.09
Gains per Quarter (342 shares)35.3231.63
Gains per Year (342 shares)141.27126.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
158841314779117
211516727295158244
3173251413142237371
4231334554190316498
5288418695237395625
6346502836285475752
7404585977332554879
846166911183806331006
951975312594277121133
1057783614004747911260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%39.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%35.03.01.089.7%35.03.01.089.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%39.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%39.00.00.0100.0%

Fundamentals of Guangxi Liuzhou Pharm Co Ltd

About Guangxi Liuzhou Pharm Co Ltd

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.

Fundamental data was last updated by Penke on 2024-03-27 22:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Guangxi Liuzhou Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guangxi Liuzhou Pharm Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 4.4% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 4.4%. The company is making a profit. +1
  • The TTM is 3.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM3.9%+0.5%
TTM3.9%YOY3.4%+0.5%
TTM3.9%5Y4.1%-0.2%
5Y4.1%10Y4.0%+0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%1.9%+2.5%
TTM3.9%2.2%+1.7%
YOY3.4%2.4%+1.0%
5Y4.1%2.2%+1.9%
10Y4.0%2.1%+1.9%
1.1.2. Return on Assets

Shows how efficient Guangxi Liuzhou Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • 1.1% Return on Assets means that Guangxi Liuzhou Pharm Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.0%+0.1%
TTM1.0%YOY0.9%+0.1%
TTM1.0%5Y1.2%-0.1%
5Y1.2%10Y1.2%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%0.8%+0.3%
TTM1.0%0.9%+0.1%
YOY0.9%0.8%+0.1%
5Y1.2%0.9%+0.3%
10Y1.2%1.0%+0.2%
1.1.3. Return on Equity

Shows how efficient Guangxi Liuzhou Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • 3.6% Return on Equity means Guangxi Liuzhou Pharm Co Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM3.2%+0.4%
TTM3.2%YOY2.8%+0.4%
TTM3.2%5Y3.4%-0.2%
5Y3.4%10Y3.7%-0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%2.1%+1.5%
TTM3.2%2.5%+0.7%
YOY2.8%2.2%+0.6%
5Y3.4%2.3%+1.1%
10Y3.7%2.4%+1.3%

1.2. Operating Efficiency of Guangxi Liuzhou Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guangxi Liuzhou Pharm Co Ltd is operating .

  • Measures how much profit Guangxi Liuzhou Pharm Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.5%-4.5%
TTM4.5%YOY5.9%-1.3%
TTM4.5%5Y6.1%-1.5%
5Y6.1%10Y3.3%+2.8%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-3.1%
TTM4.5%2.6%+1.9%
YOY5.9%3.5%+2.4%
5Y6.1%3.3%+2.8%
10Y3.3%2.0%+1.3%
1.2.2. Operating Ratio

Measures how efficient Guangxi Liuzhou Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are ¥1.81 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 1.811. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.823. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.811TTM1.823-0.011
TTM1.823YOY1.827-0.005
TTM1.8235Y1.817+0.006
5Y1.81710Y1.397+0.419
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8111.369+0.442
TTM1.8231.369+0.454
YOY1.8271.413+0.414
5Y1.8171.312+0.505
10Y1.3971.210+0.187

1.3. Liquidity of Guangxi Liuzhou Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guangxi Liuzhou Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.48 means the company has ¥1.48 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 1.475. The company is just able to pay all its short-term debts.
  • The TTM is 1.482. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.475TTM1.482-0.006
TTM1.482YOY1.507-0.026
TTM1.4825Y1.501-0.019
5Y1.50110Y0.811+0.689
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4751.366+0.109
TTM1.4821.418+0.064
YOY1.5071.403+0.104
5Y1.5011.408+0.093
10Y0.8111.299-0.488
1.3.2. Quick Ratio

Measures if Guangxi Liuzhou Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.91 means the company can pay off ¥0.91 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 0.912. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.905. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.912TTM0.905+0.008
TTM0.905YOY0.922-0.017
TTM0.9055Y0.955-0.051
5Y0.95510Y0.963-0.007
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9120.758+0.154
TTM0.9050.757+0.148
YOY0.9220.828+0.094
5Y0.9550.814+0.141
10Y0.9630.850+0.113

1.4. Solvency of Guangxi Liuzhou Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guangxi Liuzhou Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.67 means that Guangxi Liuzhou Pharm Co Ltd assets are financed with 66.8% credit (debt) and the remaining percentage (100% - 66.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 0.668. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.665. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.668TTM0.665+0.004
TTM0.665YOY0.655+0.009
TTM0.6655Y0.642+0.023
5Y0.64210Y0.602+0.040
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6680.617+0.051
TTM0.6650.606+0.059
YOY0.6550.608+0.047
5Y0.6420.610+0.032
10Y0.6020.593+0.009
1.4.2. Debt to Equity Ratio

Measures if Guangxi Liuzhou Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 215.2% means that company has ¥2.15 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The MRQ is 2.152. The company is just not able to pay all its debts with equity.
  • The TTM is 2.119. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.152TTM2.119+0.033
TTM2.119YOY2.028+0.091
TTM2.1195Y1.922+0.197
5Y1.92210Y1.808+0.114
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1521.698+0.454
TTM2.1191.678+0.441
YOY2.0281.752+0.276
5Y1.9221.733+0.189
10Y1.8081.738+0.070

2. Market Valuation of Guangxi Liuzhou Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangxi Liuzhou Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guangxi Liuzhou Pharm Co Ltd to the Medical Distribution industry mean.
  • A PE ratio of 8.44 means the investor is paying ¥8.44 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The EOD is 8.246. Based on the earnings, the company is underpriced. +1
  • The MRQ is 8.438. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.671. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD8.246MRQ8.438-0.192
MRQ8.438TTM10.671-2.234
TTM10.671YOY12.753-2.081
TTM10.6715Y13.495-2.824
5Y13.49510Y39.859-26.363
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD8.24613.469-5.223
MRQ8.43814.623-6.185
TTM10.67118.845-8.174
YOY12.75318.249-5.496
5Y13.49517.230-3.735
10Y39.85919.682+20.177
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The EOD is 8.855. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.061. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.478. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.855MRQ9.061-0.206
MRQ9.061TTM4.478+4.583
TTM4.478YOY2.121+2.357
TTM4.4785Y-1.723+6.201
5Y-1.72310Y-10.990+9.267
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD8.8556.142+2.713
MRQ9.0614.510+4.551
TTM4.4787.516-3.038
YOY2.1215.244-3.123
5Y-1.7232.484-4.207
10Y-10.9901.762-12.752
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guangxi Liuzhou Pharm Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 1.14 means the investor is paying ¥1.14 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangxi Liuzhou Pharm Co Ltd:

  • The EOD is 1.110. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.136. Based on the equity, the company is underpriced. +1
  • The TTM is 1.224. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.110MRQ1.136-0.026
MRQ1.136TTM1.224-0.088
TTM1.224YOY1.048+0.176
TTM1.2245Y1.655-0.431
5Y1.65510Y5.270-3.614
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD1.1101.132-0.022
MRQ1.1361.178-0.042
TTM1.2241.224+0.000
YOY1.0481.307-0.259
5Y1.6551.386+0.269
10Y5.2702.166+3.104
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangxi Liuzhou Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6810.442+54%0.335+103%0.418+63%0.487+40%
Book Value Per Share--18.99218.290+4%16.629+14%15.178+25%10.961+73%
Current Ratio--1.4751.4820%1.507-2%1.501-2%0.811+82%
Debt To Asset Ratio--0.6680.665+1%0.655+2%0.642+4%0.602+11%
Debt To Equity Ratio--2.1522.119+2%2.028+6%1.922+12%1.808+19%
Dividend Per Share--0.0610.305-80%0.269-77%0.251-76%0.217-72%
Eps--0.6390.553+16%0.442+45%0.479+33%0.351+82%
Free Cash Flow Per Share--0.5950.220+171%0.815-27%0.203+193%0.145+310%
Free Cash Flow To Equity Per Share--0.595-0.478+180%1.111-46%0.440+35%0.511+17%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--48.756--------
Intrinsic Value_10Y_min--40.938--------
Intrinsic Value_1Y_max--1.818--------
Intrinsic Value_1Y_min--1.784--------
Intrinsic Value_3Y_max--7.801--------
Intrinsic Value_3Y_min--7.401--------
Intrinsic Value_5Y_max--16.603--------
Intrinsic Value_5Y_min--15.209--------
Market Cap7638671122.560-2%7816899036.1808115729197.538-4%6301856792.885+24%8627115775.595-9%13802580782.268-43%
Net Profit Margin--0.0440.039+13%0.034+29%0.041+7%0.040+11%
Operating Margin---0.045-100%0.059-100%0.061-100%0.033-100%
Operating Ratio--1.8111.823-1%1.827-1%1.8170%1.397+30%
Pb Ratio1.110-2%1.1361.224-7%1.048+8%1.655-31%5.270-78%
Pe Ratio8.246-2%8.43810.671-21%12.753-34%13.495-37%39.859-79%
Price Per Share21.090-2%21.58022.405-4%17.393+24%23.806-9%38.102-43%
Price To Free Cash Flow Ratio8.855-2%9.0614.478+102%2.121+327%-1.723+119%-10.990+221%
Price To Total Gains Ratio28.425-2%29.08538.832-25%39.796-27%40.249-28%103.259-72%
Quick Ratio--0.9120.905+1%0.922-1%0.955-4%0.963-5%
Return On Assets--0.0110.010+10%0.009+24%0.012-3%0.012-9%
Return On Equity--0.0360.032+12%0.028+28%0.034+5%0.037-3%
Total Gains Per Share--0.7420.746-1%0.604+23%0.668+11%0.704+5%
Usd Book Value--952123958.191916923902.578+4%833866782.259+14%761242462.189+25%549622944.809+73%
Usd Book Value Change Per Share--0.0940.061+54%0.046+103%0.058+63%0.067+40%
Usd Book Value Per Share--2.6292.531+4%2.301+14%2.101+25%1.517+73%
Usd Dividend Per Share--0.0080.042-80%0.037-77%0.035-76%0.030-72%
Usd Eps--0.0880.076+16%0.061+45%0.066+33%0.049+82%
Usd Free Cash Flow--29849858.60611028785.881+171%40867378.399-27%10197205.908+193%4108249.467+627%
Usd Free Cash Flow Per Share--0.0820.030+171%0.113-27%0.028+193%0.020+310%
Usd Free Cash Flow To Equity Per Share--0.082-0.066+180%0.154-46%0.061+35%0.071+17%
Usd Market Cap1057192083.362-2%1081858826.6071123216920.939-4%872176980.135+24%1193992823.342-9%1910277180.266-43%
Usd Price Per Share2.919-2%2.9873.101-4%2.407+24%3.295-9%5.273-43%
Usd Profit--32054028.92827708270.630+16%22168024.508+45%24043072.755+33%17622255.638+82%
Usd Revenue--729722096.471707468742.915+3%639342351.537+14%590512297.597+24%437256903.239+67%
Usd Total Gains Per Share--0.1030.103-1%0.084+23%0.092+11%0.097+5%
 EOD+4 -4MRQTTM+22 -13YOY+19 -165Y+22 -1310Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Guangxi Liuzhou Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-158.246
Price to Book Ratio (EOD)Between0-11.110
Net Profit Margin (MRQ)Greater than00.044
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.912
Current Ratio (MRQ)Greater than11.475
Debt to Asset Ratio (MRQ)Less than10.668
Debt to Equity Ratio (MRQ)Less than12.152
Return on Equity (MRQ)Greater than0.150.036
Return on Assets (MRQ)Greater than0.050.011
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Guangxi Liuzhou Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.855
Ma 20Greater thanMa 5021.227
Ma 50Greater thanMa 10019.281
Ma 100Greater thanMa 20019.748
OpenGreater thanClose21.020
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets20,736,665
Total Liabilities13,857,157
Total Stockholder Equity6,439,685
 As reported
Total Liabilities 13,857,157
Total Stockholder Equity+ 6,439,685
Total Assets = 20,736,665

Assets

Total Assets20,736,665
Total Current Assets18,306,344
Long-term Assets2,430,321
Total Current Assets
Cash And Cash Equivalents 3,224,373
Net Receivables 11,322,284
Inventory 2,696,140
Other Current Assets 5,757
Total Current Assets  (as reported)18,306,344
Total Current Assets  (calculated)17,248,554
+/- 1,057,790
Long-term Assets
Property Plant Equipment 1,224,824
Goodwill 765,460
Intangible Assets 240,964
Long-term Assets Other 65,058
Long-term Assets  (as reported)2,430,321
Long-term Assets  (calculated)2,296,306
+/- 134,014

Liabilities & Shareholders' Equity

Total Current Liabilities12,408,401
Long-term Liabilities1,448,755
Total Stockholder Equity6,439,685
Total Current Liabilities
Short Long Term Debt 3,365,399
Accounts payable 7,870,726
Total Current Liabilities  (as reported)12,408,401
Total Current Liabilities  (calculated)11,236,125
+/- 1,172,276
Long-term Liabilities
Long term Debt 997,103
Capital Lease Obligations Min Short Term Debt147,797
Long-term Liabilities Other 232,788
Long-term Liabilities  (as reported)1,448,755
Long-term Liabilities  (calculated)1,377,689
+/- 71,067
Total Stockholder Equity
Retained Earnings 3,728,390
Total Stockholder Equity (as reported)6,439,685
Total Stockholder Equity (calculated)3,728,390
+/- 2,711,295
Other
Capital Stock362,229
Common Stock Shares Outstanding 362,229
Net Debt 1,138,130
Net Invested Capital 10,802,187
Net Working Capital 5,897,943
Property Plant and Equipment Gross 1,224,824



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
> Total Assets 
1,573,669
2,029,382
2,697,874
0
3,074,632
3,324,561
3,735,623
3,656,209
3,916,716
4,157,970
4,304,984
5,814,273
5,656,846
5,726,707
6,278,927
6,537,939
6,680,823
7,262,043
7,554,049
8,273,602
8,488,140
9,078,439
9,772,635
11,239,782
12,062,900
12,724,098
11,958,214
13,360,543
13,222,791
14,253,219
14,807,734
15,110,933
16,316,927
16,651,863
15,874,751
16,959,060
18,074,344
19,244,314
18,606,992
18,905,520
20,902,108
20,736,665
20,736,66520,902,10818,905,52018,606,99219,244,31418,074,34416,959,06015,874,75116,651,86316,316,92715,110,93314,807,73414,253,21913,222,79113,360,54311,958,21412,724,09812,062,90011,239,7829,772,6359,078,4398,488,1408,273,6027,554,0497,262,0436,680,8236,537,9396,278,9275,726,7075,656,8465,814,2734,304,9844,157,9703,916,7163,656,2093,735,6233,324,5613,074,63202,697,8742,029,3821,573,669
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,220,668
8,025,129
9,390,180
10,256,543
10,898,610
10,094,286
11,493,875
11,335,395
12,322,971
12,786,307
12,849,200
13,925,916
14,233,795
13,387,645
14,475,466
15,626,697
16,804,535
16,125,160
16,421,324
18,501,674
18,306,344
18,306,34418,501,67416,421,32416,125,16016,804,53515,626,69714,475,46613,387,64514,233,79513,925,91612,849,20012,786,30712,322,97111,335,39511,493,87510,094,28610,898,61010,256,5439,390,1808,025,1298,220,668000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
525,867
1,240,603
940,449
1,622,821
1,428,644
1,915,191
2,110,609
2,254,390
2,494,884
3,495,891
1,702,253
2,516,252
2,281,543
3,415,544
3,136,318
3,784,949
4,336,235
3,854,653
2,615,024
4,472,664
3,224,373
3,224,3734,472,6642,615,0243,854,6534,336,2353,784,9493,136,3183,415,5442,281,5432,516,2521,702,2533,495,8912,494,8842,254,3902,110,6091,915,1911,428,6441,622,821940,4491,240,603525,867000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,000
0
330,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000330,000075,0000000000000000000000000
       Net Receivables 
755,434
972,459
1,362,089
0
1,772,534
2,093,784
1,858,448
2,328,141
2,432,118
2,754,001
2,417,317
3,053,533
2,931,787
3,264,219
2,985,734
3,853,518
3,898,887
4,392,624
4,026,210
4,803,832
4,981,219
5,609,967
5,214,918
6,167,118
6,327,325
7,056,619
6,378,549
7,522,471
7,280,089
7,994,763
7,471,885
9,082,463
9,304,343
9,829,829
7,876,439
9,259,330
9,603,671
10,153,405
9,345,337
10,653,567
11,000,299
11,322,284
11,322,28411,000,29910,653,5679,345,33710,153,4059,603,6719,259,3307,876,4399,829,8299,304,3439,082,4637,471,8857,994,7637,280,0897,522,4716,378,5497,056,6196,327,3256,167,1185,214,9185,609,9674,981,2194,803,8324,026,2104,392,6243,898,8873,853,5182,985,7343,264,2192,931,7873,053,5332,417,3172,754,0012,432,1182,328,1411,858,4482,093,7841,772,53401,362,089972,459755,434
       Other Current Assets 
42,263
42,712
56,750
0
68,306
77,333
72,143
60,770
73,603
73,746
91,127
82,533
85,367
115,455
132,621
93,095
146,221
167,808
209,765
582,428
202,370
798,601
231,304
324,097
340,978
306,426
289,860
241,511
325,453
273,431
252,088
291,872
298,598
230,240
290,524
237,103
307,799
275,659
462,911
454,905
411,945
5,757
5,757411,945454,905462,911275,659307,799237,103290,524230,240298,598291,872252,088273,431325,453241,511289,860306,426340,978324,097231,304798,601202,370582,428209,765167,808146,22193,095132,621115,45585,36782,53391,12773,74673,60360,77072,14377,33368,306056,75042,71242,263
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,849,602
1,806,357
1,825,488
1,863,928
1,866,667
1,887,396
1,930,248
2,021,426
2,261,733
2,391,012
2,418,067
2,487,106
2,483,595
2,447,647
2,439,779
2,481,831
2,484,196
2,400,435
2,430,321
2,430,3212,400,4352,484,1962,481,8312,439,7792,447,6472,483,5952,487,1062,418,0672,391,0122,261,7332,021,4261,930,2481,887,3961,866,6671,863,9281,825,4881,806,3571,849,60200000000000000000000000
       Property Plant Equipment 
8,808
14,488
70,728
0
92,523
132,162
181,616
215,393
227,071
254,981
296,979
311,182
321,843
326,299
371,050
381,855
413,023
457,935
515,776
533,705
547,686
550,220
601,687
607,606
626,385
645,174
687,233
696,271
721,052
752,041
791,224
1,043,448
1,173,420
1,206,699
1,211,788
1,226,812
1,199,435
1,193,310
1,202,837
1,207,515
1,197,347
1,224,824
1,224,8241,197,3471,207,5151,202,8371,193,3101,199,4351,226,8121,211,7881,206,6991,173,4201,043,448791,224752,041721,052696,271687,233645,174626,385607,606601,687550,220547,686533,705515,776457,935413,023381,855371,050326,299321,843311,182296,979254,981227,071215,393181,616132,16292,523070,72814,4888,808
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,200
3,200
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460
765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,460765,4603,2003,20000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,046
75,046
75,046
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000075,04675,04675,046000000000000000000000
       Intangible Assets 
38,468
42,752
64,177
0
65,770
65,326
65,069
64,619
74,116
84,272
83,714
83,170
103,259
102,700
102,021
101,354
100,687
100,236
101,139
100,627
110,470
106,536
141,823
170,333
54,897
165,566
197,554
194,926
190,547
187,012
208,087
206,705
210,075
204,297
226,822
220,717
233,856
228,604
256,501
250,828
245,593
240,964
240,964245,593250,828256,501228,604233,856220,717226,822204,297210,075206,705208,087187,012190,547194,926197,554165,56654,897170,333141,823106,536110,470100,627101,139100,236100,687101,354102,021102,700103,25983,17083,71484,27274,11664,61965,06965,32665,770064,17742,75238,468
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,765
125,008
119,666
85,021
75,916
71,887
828,573
110,584
99,419
94,180
92,295
139,177
124,382
106,315
111,257
127,802
128,210
59,994
65,058
65,05859,994128,210127,802111,257106,315124,382139,17792,29594,18099,419110,584828,57371,88775,91685,021119,666125,008189,76500000000000000000000000
> Total Liabilities 
1,299,436
1,650,795
2,196,869
0
2,532,050
2,728,931
2,561,701
2,438,058
2,672,750
2,851,973
2,944,349
2,759,539
2,604,292
2,586,888
3,041,187
3,212,174
3,334,934
3,810,019
3,985,530
4,587,083
4,772,315
5,225,547
5,725,598
7,021,012
7,812,656
8,270,404
7,300,692
8,350,886
8,161,739
8,966,690
9,363,160
9,461,903
10,745,945
10,895,704
10,068,481
10,921,800
12,057,297
13,004,696
12,241,644
12,282,642
14,269,151
13,857,157
13,857,15714,269,15112,282,64212,241,64413,004,69612,057,29710,921,80010,068,48110,895,70410,745,9459,461,9039,363,1608,966,6908,161,7398,350,8867,300,6928,270,4047,812,6567,021,0125,725,5985,225,5474,772,3154,587,0833,985,5303,810,0193,334,9343,212,1743,041,1872,586,8882,604,2922,759,5392,944,3492,851,9732,672,7502,438,0582,561,7012,728,9312,532,05002,196,8691,650,7951,299,436
   > Total Current Liabilities 
1,277,551
1,631,230
2,168,451
0
2,456,832
2,643,712
2,438,109
2,341,437
2,622,957
2,801,607
2,882,425
2,697,850
2,542,838
2,525,668
2,980,202
3,151,481
3,274,533
3,749,910
3,925,713
4,527,559
4,713,082
5,066,606
5,231,575
6,543,985
7,352,658
7,827,386
6,872,726
7,410,438
7,226,338
8,047,199
8,211,639
8,059,560
9,217,783
9,375,785
8,628,846
9,404,259
10,560,311
11,519,786
10,827,718
10,800,338
12,834,254
12,408,401
12,408,40112,834,25410,800,33810,827,71811,519,78610,560,3119,404,2598,628,8469,375,7859,217,7838,059,5608,211,6398,047,1997,226,3387,410,4386,872,7267,827,3867,352,6586,543,9855,231,5755,066,6064,713,0824,527,5593,925,7133,749,9103,274,5333,151,4812,980,2022,525,6682,542,8382,697,8502,882,4252,801,6072,622,9572,341,4372,438,1092,643,7122,456,83202,168,4511,631,2301,277,551
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,550,170
2,534,170
2,485,220
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,485,2202,534,1701,550,17000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,550,170
2,534,170
2,485,220
1,888,720
2,491,550
2,646,550
2,748,000
2,771,590
2,941,090
3,414,397
3,325,697
2,711,207
3,500,997
3,930,939
4,140,269
2,996,060
3,334,567
3,389,420
3,365,399
3,365,3993,389,4203,334,5672,996,0604,140,2693,930,9393,500,9972,711,2073,325,6973,414,3972,941,0902,771,5902,748,0002,646,5502,491,5501,888,7202,485,2202,534,1701,550,17000000000000000000000000
       Accounts payable 
993,090
1,160,583
1,541,652
0
1,743,948
1,848,389
1,816,322
1,853,770
1,956,356
2,098,217
2,073,854
2,268,405
2,421,191
2,314,679
2,598,606
2,746,124
2,885,957
2,947,462
3,005,867
3,011,805
2,947,458
3,176,725
3,188,677
4,206,575
3,920,640
4,412,283
3,997,041
3,989,649
3,589,438
4,299,947
4,439,216
4,129,012
4,771,251
5,083,742
4,802,780
4,750,265
5,525,902
6,261,306
6,526,373
6,344,019
8,253,101
7,870,726
7,870,7268,253,1016,344,0196,526,3736,261,3065,525,9024,750,2654,802,7805,083,7424,771,2514,129,0124,439,2164,299,9473,589,4383,989,6493,997,0414,412,2833,920,6404,206,5753,188,6773,176,7252,947,4583,011,8053,005,8672,947,4622,885,9572,746,1242,598,6062,314,6792,421,1912,268,4052,073,8542,098,2171,956,3561,853,7701,816,3221,848,3891,743,94801,541,6521,160,583993,090
       Other Current Liabilities 
35,961
48,507
31,389
0
36,515
33,653
61,898
56,247
107,562
115,896
127,450
89,445
71,647
100,989
118,597
88,686
71,906
125,778
296,176
432,084
521,955
609,329
683,775
785,000
872,823
919,626
922,165
926,803
959,506
996,621
944,737
988,210
1,002,053
965,112
975,496
1,075,326
965,231
1,021,504
1,036,903
1,035,219
1,030,581
0
01,030,5811,035,2191,036,9031,021,504965,2311,075,326975,496965,1121,002,053988,210944,737996,621959,506926,803922,165919,626872,823785,000683,775609,329521,955432,084296,176125,77871,90688,686118,597100,98971,64789,445127,450115,896107,56256,24761,89833,65336,515031,38948,50735,961
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
477,028
459,998
443,018
427,966
940,449
935,401
919,491
1,151,521
1,402,343
1,528,162
1,519,919
1,439,635
1,517,542
1,496,986
1,484,910
1,413,926
1,482,304
1,434,898
1,448,755
1,448,7551,434,8981,482,3041,413,9261,484,9101,496,9861,517,5421,439,6351,519,9191,528,1621,402,3431,151,521919,491935,401940,449427,966443,018459,998477,02800000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,550,170
-2,534,170
-2,485,220
0
0
0
0
0
199,601
282,404
284,642
190,848
198,102
157,699
152,891
139,212
150,604
156,518
147,797
147,797156,518150,604139,212152,891157,699198,102190,848284,642282,404199,60100000-2,485,220-2,534,170-1,550,17000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
420,335
403,785
6,885
7,864
7,864
7,864
7,864
229,712
230,320
230,320
230,320
232,219
208,219
229,194
237,694
233,596
231,456
231,288
232,788
232,788231,288231,456233,596237,694229,194208,219232,219230,320230,320230,320229,7127,8647,8647,8647,8646,885403,785420,33500000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,116
72,577
81,170
84,290
91,410
90,441
92,986
95,214
100,668
96,002
100,885
99,253
97,156
91,526
87,016
80,624
73,957
0
69,189
64,657
0
064,65769,189073,95780,62487,01691,52697,15699,253100,88596,002100,66895,21492,98690,44191,41084,29081,17072,57758,116000000000000000000000
> Total Stockholder Equity
274,233
378,587
501,005
501,005
542,582
580,822
1,155,646
1,196,934
1,221,361
1,278,775
1,329,149
3,018,314
3,016,381
3,098,800
3,190,022
3,273,745
3,282,186
3,379,992
3,491,758
3,605,011
3,625,204
3,760,433
3,846,463
3,975,811
4,012,803
4,204,173
4,372,782
4,710,698
4,743,747
4,957,192
5,098,596
5,306,534
5,210,743
5,379,042
5,460,085
5,681,079
5,655,326
5,870,818
5,968,965
6,217,261
6,208,080
6,439,685
6,439,6856,208,0806,217,2615,968,9655,870,8185,655,3265,681,0795,460,0855,379,0425,210,7435,306,5345,098,5964,957,1924,743,7474,710,6984,372,7824,204,1734,012,8033,975,8113,846,4633,760,4333,625,2043,605,0113,491,7583,379,9923,282,1863,273,7453,190,0223,098,8003,016,3813,018,3141,329,1491,278,7751,221,3611,196,9341,155,646580,822542,582501,005501,005378,587274,233
   Common Stock
90,000
90,000
90,000
0
90,000
90,000
112,500
112,500
112,500
112,500
112,500
142,348
142,348
142,348
142,348
142,348
185,053
185,053
185,053
185,053
259,073
259,073
259,073
259,073
259,073
259,073
259,073
259,073
362,670
362,663
362,664
362,442
362,440
362,360
362,360
362,362
362,363
362,228
0
362,228
362,229
0
0362,229362,2280362,228362,363362,362362,360362,360362,440362,442362,664362,663362,670259,073259,073259,073259,073259,073259,073259,073259,073185,053185,053185,053185,053142,348142,348142,348142,348142,348112,500112,500112,500112,500112,50090,00090,000090,00090,00090,000
   Retained Earnings 
90,870
186,358
297,667
0
366,051
405,786
449,271
490,559
514,987
572,401
622,774
686,670
684,737
767,156
858,377
942,100
950,541
1,048,347
1,160,113
1,273,367
1,293,559
1,428,788
1,566,164
1,554,889
1,591,881
1,783,251
2,092,877
2,277,885
2,311,599
2,525,204
2,628,438
2,836,188
2,740,395
2,909,383
2,974,795
3,195,741
3,169,971
3,376,168
3,235,688
3,763,476
3,763,502
3,728,390
3,728,3903,763,5023,763,4763,235,6883,376,1683,169,9713,195,7412,974,7952,909,3832,740,3952,836,1882,628,4382,525,2042,311,5992,277,8852,092,8771,783,2511,591,8811,554,8891,566,1641,428,7881,293,5591,273,3671,160,1131,048,347950,541942,100858,377767,156684,737686,670622,774572,401514,987490,559449,271405,786366,0510297,667186,35890,870
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
152,907
152,907
152,875
152,870
152,868
154,229
152,867
152,866
152,854
152,850
152,850
0
152,849
152,848
0
0152,848152,8490152,850152,850152,854152,866152,867154,229152,868152,870152,875152,907152,907000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue20,447,073
Cost of Revenue-18,077,250
Gross Profit2,369,8242,369,824
 
Operating Income (+$)
Gross Profit2,369,824
Operating Expense-19,173,896
Operating Income1,273,177-16,804,072
 
Operating Expense (+$)
Research Development30,748
Selling General Administrative649,286
Selling And Marketing Expenses-
Operating Expense19,173,896680,034
 
Net Interest Income (+$)
Interest Income69,470
Interest Expense-282,936
Other Finance Cost-14,212
Net Interest Income-199,255
 
Pretax Income (+$)
Operating Income1,273,177
Net Interest Income-199,255
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,026,8971,273,177
EBIT - interestExpense = -282,936
800,817
1,083,753
Interest Expense282,936
Earnings Before Interest and Taxes (EBIT)-1,309,833
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,026,897
Tax Provision-154,422
Net Income From Continuing Ops872,474872,474
Net Income800,817
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-199,255
 

Technical Analysis of Guangxi Liuzhou Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangxi Liuzhou Pharm Co Ltd. The general trend of Guangxi Liuzhou Pharm Co Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangxi Liuzhou Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangxi Liuzhou Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 22.20 < 22.55 < 23.64.

The bearish price targets are: 19.74 > 18.37 > 15.12.

Tweet this
Guangxi Liuzhou Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangxi Liuzhou Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangxi Liuzhou Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangxi Liuzhou Pharm Co Ltd. The current macd is 0.56510935.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangxi Liuzhou Pharm Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Guangxi Liuzhou Pharm Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Guangxi Liuzhou Pharm Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangxi Liuzhou Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangxi Liuzhou Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangxi Liuzhou Pharm Co Ltd. The current adx is 39.78.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Guangxi Liuzhou Pharm Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Guangxi Liuzhou Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangxi Liuzhou Pharm Co Ltd. The current sar is 22.10.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangxi Liuzhou Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangxi Liuzhou Pharm Co Ltd. The current rsi is 55.86. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Guangxi Liuzhou Pharm Co Ltd Daily Relative Strength Index (RSI) ChartGuangxi Liuzhou Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangxi Liuzhou Pharm Co Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangxi Liuzhou Pharm Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guangxi Liuzhou Pharm Co Ltd Daily Stochastic Oscillator ChartGuangxi Liuzhou Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangxi Liuzhou Pharm Co Ltd. The current cci is -30.99301073.

Guangxi Liuzhou Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartGuangxi Liuzhou Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangxi Liuzhou Pharm Co Ltd. The current cmo is 1.83889252.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Guangxi Liuzhou Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangxi Liuzhou Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangxi Liuzhou Pharm Co Ltd. The current willr is -86.71875.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guangxi Liuzhou Pharm Co Ltd Daily Williams %R ChartGuangxi Liuzhou Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangxi Liuzhou Pharm Co Ltd.

Guangxi Liuzhou Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangxi Liuzhou Pharm Co Ltd. The current atr is 0.63655871.

Guangxi Liuzhou Pharm Co Ltd Daily Average True Range (ATR) ChartGuangxi Liuzhou Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangxi Liuzhou Pharm Co Ltd. The current obv is 213,967,365.

Guangxi Liuzhou Pharm Co Ltd Daily On-Balance Volume (OBV) ChartGuangxi Liuzhou Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangxi Liuzhou Pharm Co Ltd. The current mfi is 45.17.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guangxi Liuzhou Pharm Co Ltd Daily Money Flow Index (MFI) ChartGuangxi Liuzhou Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangxi Liuzhou Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Guangxi Liuzhou Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangxi Liuzhou Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.855
Ma 20Greater thanMa 5021.227
Ma 50Greater thanMa 10019.281
Ma 100Greater thanMa 20019.748
OpenGreater thanClose21.020
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guangxi Liuzhou Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangxi Liuzhou Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangxi Liuzhou Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangxi Liuzhou Pharm Co Ltd

I send you an email if I find something interesting about Guangxi Liuzhou Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangxi Liuzhou Pharm Co Ltd.

Receive notifications about Guangxi Liuzhou Pharm Co Ltd in your mailbox!